Form 4: Clearfield Director Sells Shares Under 10b5-1 Plan

Clearfield Director Donald R. Hayward sold 3,595 shares of common stock at a weighted average price of $32 per share as part of a pre-arranged 10b5-1 plan.

Summary

• Donald R. Hayward, a Director of Clearfield, Inc. (CLFD), reported a sale of common stock.
• The transaction involved the disposition of 3,595 shares of Clearfield common stock.
• The shares were sold at a weighted average price of $32 per share, with individual transactions ranging from $32.00 to $32.06.
• The sale was executed on February 19, 2026.
• Following this transaction, Donald R. Hayward beneficially owns 10,870 shares of common stock.
• The transaction was made pursuant to a Rule 10b5-1(c) contract, instruction, or written plan.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event. The sale is a routine insider transaction executed under a pre-arranged 10b5-1 plan, which typically minimizes its impact as a signal of management sentiment.

Negatives

• A director's sale of shares, even if pre-planned, can sometimes be interpreted by the market as a slight reduction in insider confidence, though this is mitigated by the 10b5-1 plan.

Future Outlook

This filing does not contain any forward-looking statements or guidance regarding the company's future performance or outlook.

Industry Context

StockSavvy.ai notes that insider transactions, particularly sales, are routinely monitored by investors for signals regarding management's perception of the company's value. However, sales executed under a Rule 10b5-1 plan are pre-scheduled and generally carry less signaling weight than open-market, discretionary sales, as they are often for personal financial planning purposes rather than a reaction to new, material non-public information.

Stakeholder Impact

• Shareholders: May observe the director's sale, but the pre-planned nature under Rule 10b5-1 mitigates concerns about immediate insider sentiment.

Key Dates

Recommendation

The filing reports a pre-planned sale by a director, which is a routine event and does not indicate a significant change in company fundamentals or outlook. The transaction is not substantial enough to warrant a change in investment thesis, thus a 'hold' recommendation is appropriate.

Keywords

Clearfield, CLFD, Form 4, insider trading, director sale, common stock, 10b5-1 plan